In this piece, we will take a look at five high growth U.K. stocks to buy. For more stocks, head on over to 11 High Growth U.K. Stocks to Buy.
5. Adaptimmune Therapeutics plc (NASDAQ:ADAP)
Q/Q Sales Growth: 483%
Number of Hedge Fund Holders in Q4 2022: 22
Adaptimmune Therapeutics plc (NASDAQ:ADAP) is a biotechnology firm that develops tumor and cancer treatments. Some cancers that the firm is taking aim at include those of the lungs, head, and neck. The company is based in Abingdon, United Kingdom.
Adaptimmune Therapeutics plc (NASDAQ:ADAP) had a bumper third quarter of fiscal 2022 ending in September that saw it post $7 million in revenue for an outlandish 483% annual growth. By the end of December 2022, 22 of the 943 hedge funds polled by Insider Monkey had invested in the company.
Adaptimmune Therapeutics plc (NASDAQ:ADAP)’s largest shareholder in our database is David Goel and Paul Ferri’s Matrix Capital Management which owns 38 million shares that are worth $56 million.
Follow Adaptimmune Therapeutics Plc (NASDAQ:ADAP)
Follow Adaptimmune Therapeutics Plc (NASDAQ:ADAP)
4. Wejo Group Limited (NASDAQ:WEJO)
Q/Q Sales Growth: 632%
Number of Hedge Fund Holders in Q4 2022: 14
Wejo Group Limited (NASDAQ:WEJO) is a software company headquartered in Manchester. The firm provides a platform that lets users share connected vehicle data.
Wejo Group Limited (NASDAQ:WEJO) earned $2.5 million in revenue during 2022’s third quarter, which let it post a 632% annual net sales growth over 2021’s September quarter. The firm is currently on a 180 day notice from the NASDAQ for a potential delisting since its shares are trading below $1. After scouring through 943 hedge fund portfolios for last year’s fourth quarter, Insider Monkey discovered that 14 had held a stake in the company
Wejo Group Limited (NASDAQ:WEJO)’s largest shareholder is Ben Levine, Andrew Manuel, and Stefan Renold’s LMR Partners which owns 2.6 million shares that are worth $1.2 million.
Follow Wejo Group Ltd
Follow Wejo Group Ltd
3. Vaccitech plc (NASDAQ:VACC)
Q/Q Sales Growth: 32,347%
Number of Hedge Fund Holders in Q4 2022: 3
Vaccitech plc (NASDAQ:VACC) is a biotechnology company developing treatments for hepatitis B, cancer, and other infectious diseases.
For its September 2022 quarter, Vaccitech plc (NASDAQ:VACC) raked in $6.1 million in revenue, marking for a 32,347% annual growth. Insider Monkey took a look at 943 hedge fund portfolios for 2022’s fourth quarter and found out that 3 had bought the firm’s shares.
Vaccitech plc (NASDAQ:VACC)’s largest investor is Michael Platt and William Reeves’ BlueCrest Capital Mgmt. which owns 543,673 shares that are worth $1.2 million.
Follow Barinthus Biotherapeutics Plc.
Follow Barinthus Biotherapeutics Plc.
2. Autolus Therapeutics plc (NASDAQ:AUTL)
Q/Q Sales Growth: N/A
Number of Hedge Fund Holders in Q4 2022: 18
Autolus Therapeutics plc (NASDAQ:AUTL) is a biotechnology firm developing treatments for cancers such as myeloma and neuroblastoma. The firm is based in London, United Kingdom.
Autolus Therapeutics plc (NASDAQ:AUTL)’s third fiscal quarter ending in September 2022 saw it post $2.3 million in revenue, yet since the year ago quarter’s revenue was $0, there is no growth percentage for this. 18 of the 943 hedge funds part of our Q4 2022 survey had bought the firm’s shares.
Autolus Therapeutics plc (NASDAQ:AUTL)’s largest investor is David Kroin’s Deep Track Capital which owns 15 million shares that are worth $28.5 million.
Follow Autolus Therapeutics Plc (NASDAQ:AUTL)
Follow Autolus Therapeutics Plc (NASDAQ:AUTL)
1. Akanda Corp. (NASDAQ:AKAN)
Q/Q Sales Growth: N/A
Number of Hedge Fund Holders in Q4 2022: 2
Akanda Corp. (NASDAQ:AKAN) is a medicinal cannabis firm that grows its own marijuana and is headquartered in New Romney, United Kingdom.
Akanda Corp. (NASDAQ:AKAN)’s fiscal quarter ending in December 2022 was the first in which it recognized material revenues according to its preliminary release. In fact, it managed to earn EUR1.8 billion in high quality medical marijuana sales during two of the three months of the quarter. Two of the 943 hedge funds polled by Insider Monkey had invested in the firm during 2022’s final quarter.
Disclosure: None. You can also take a peek at Ken Griffin’s High Dividend Stock Picks and 15 Fastest Growing Countries in Asia.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
